Recent Uncategorized
COVID 19 CORONA VIRUS: NEUROLOGY
Coronavirus can be especially dangerous for patients with neurological disorders The COVID-19 Pandemic has forced the Rowe Neurology Institute to close its Clinical Trials Site. This was done in an abundance of caution for patient safety, staff safety,
The Gut-Brain-Hypermobility Connection with Autoimmunity
By Julie Hoskin, B.S., M.B.A., N.T.P. and Vernon Rowe, MD Increased intestinal permeability has been found in every autoimmune disease in which it’s been studied. This is true for autoimmune disease of the gut like Crohn’s disease or ulcerative colitis
Clinical Trial: Central Neuropathic Pain and MS
RNI is currently enrolling patients who experience Central Neuropathic Pain (CNP) as a result of their MS. For more information contact Leigh Kreshel at 913-894-1500 ext. 155.
Clinical Trial: Spasticity in MS
Researchers are conducting a study to evaluate an investigational drug for spasticity in people with MS. View more information about this clinical trial. As one of the MS centers participating in the study, Rowe Neurology Institute is now enrolling patients.